Correlation Between Hookipa Pharma and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Hookipa Pharma and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Biomarin Pharmaceutical.
Diversification Opportunities for Hookipa Pharma and Biomarin Pharmaceutical
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Hookipa and Biomarin is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Biomarin Pharmaceutical
Given the investment horizon of 90 days Hookipa Pharma is expected to generate 3.2 times more return on investment than Biomarin Pharmaceutical. However, Hookipa Pharma is 3.2 times more volatile than Biomarin Pharmaceutical. It trades about 0.03 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.13 per unit of risk. If you would invest 77.00 in Hookipa Pharma on March 1, 2024 and sell it today you would earn a total of 1.00 from holding Hookipa Pharma or generate 1.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 98.41% |
Values | Daily Returns |
Hookipa Pharma vs. Biomarin Pharmaceutical
Performance |
Timeline |
Hookipa Pharma |
Biomarin Pharmaceutical |
Hookipa Pharma and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hookipa Pharma and Biomarin Pharmaceutical
The main advantage of trading using opposite Hookipa Pharma and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.Hookipa Pharma vs. MicroAlgo | Hookipa Pharma vs. Morningstar Unconstrained Allocation | Hookipa Pharma vs. T Rowe Price | Hookipa Pharma vs. Nt International Small Mid |
Biomarin Pharmaceutical vs. MicroAlgo | Biomarin Pharmaceutical vs. Morningstar Unconstrained Allocation | Biomarin Pharmaceutical vs. T Rowe Price | Biomarin Pharmaceutical vs. Nt International Small Mid |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |